AOS vs ORMP
Smith AO Corporation (AOS) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
Smith AO Corporation (AOS) is a specialty industrial machinery company listed on US.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Latest reported AOS revenue for 2023-12-31 was $3.85B. Net income was $556.6M. Revenue was up 2.6% from 2022-12-31 to 2023-12-31. AOS currently screens at market cap $9.73B and trailing P/E 19.1.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
AOS currently screens at market cap $9.73B and trailing P/E 19.1. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the AOS and ORMP stock pages for the full models.
Not investment advice.